普埃拉林通过调节微质中的AKT1通路来预防与败血症相关的脑病变
Shao-Peng Lin1, Lidong Zhu1, Hongjian Shi1
1Department of Emergency, the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, PR China.
概括
普埃拉林通过向微质中的AKT1通路来减少败血症相关脑病变 (SAE) 中的神经炎症. 这种天然化合物可以缓解认知障碍并保护神经元,为SAE提供潜在的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- 败血症相关脑病变 (SAE) 是一种严重并发症,尚未探索治疗途径.
- 普埃拉林以其抗炎和心脏保护作用而闻名,但其在SAE中的作用尚不清楚.
- 这项研究调查了皮亚林在SAE中调节微质介导的神经炎症的潜力.
研究的目的:
- 探索皮亚林在败血症相关脑病变 (SAE) 的治疗潜力.
- 为了研究皮亚林在调节微质介导的神经炎症中的作用机制.
- 在SAE的背景下识别puerarin的分子标.
主要方法:
- 使用脂聚糖 (LPS) 诱导SAE的小鼠模型.
- 使用行为测试 (MWM,NOR),生化测试 (ELISA) 和分子技术 (西式涂抹,qRT-PCR) 评估了Puerarin的影响.
- 网络药理学被用来确定潜在的治疗点,随后进行了体外和体内验证.
主要成果:
- 在接受LPS治疗的小鼠和微质细胞中,普埃拉林显著降低了促炎性细胞因子 (TNF-α,IL-6).
- 在SAE模型中,Puerarin治疗改善了认知缺陷,并预防了神经元细胞死亡.
- 网络药理学将AKT1确定为关键标;皮亚林抑制了AKT1酸化,其作用被AKT激活剂逆转.
结论:
- 普埃拉林对SAE具有显著的抗神经炎症作用.
- 该机制涉及到微质中的AKT1信号通路的调节.
- 普埃拉林代表了治疗毒症相关脑病变的有希望的治疗候选者.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
Regulation of the Unfolded Protein Response
2.5K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.5K


